Literature DB >> 8174982

Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment.

C P Choudari1, C Rajgopal, K R Palmer.   

Abstract

The underlying diagnosis and clinical course of 52 patients who presented with severe acute gastrointestinal haemorrhage while taking the anticoagulant warfarin is reviewed. A bleeding site was identified in 83% of cases, only slightly fewer than the 92% found in a control of group of 710 patients not taking warfarin who presented in the same four year period. The degree or duration of anticoagulation was unrelated to the frequency of establishing a diagnosis. The commonest diagnosis was peptic ulcer (25 cases) and endoscopic treatment by injection or heater probe was attempted in 23 of these. The outcome in this subgroup was compared with that in 50 closely matched control subjects who had similar risk factors for rebleeding from peptic ulcer. Permanent haemostasis was achieved in (91%) of the anticoagulated and in 92% of the control patients. There were no complications related to endoscopy. Patients who present with acute gastrointestinal haemorrhage while taking warfarin usually bleed from mucosal disease. They should be endoscoped after resuscitation and those with major bleeding from a peptic ulcer should be offered endoscopic treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174982      PMCID: PMC1374792          DOI: 10.1136/gut.35.4.464

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  Laboratory control of oral anticoagulants.

Authors:  L Poller
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

2.  Acute gastrointestinal bleeding in anticoagulated patients: a prospective evaluation.

Authors:  N Tabibian
Journal:  Am J Gastroenterol       Date:  1989-01       Impact factor: 10.864

3.  Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy.

Authors:  C M Wilcox; C D Truss
Journal:  Am J Med       Date:  1988-04       Impact factor: 4.965

4.  Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement.

Authors:  J Dale; E Myhre; D Loew
Journal:  Am Heart J       Date:  1980-06       Impact factor: 4.749

5.  A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.

Authors:  J C Forfar
Journal:  Br Heart J       Date:  1979-08

6.  Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospital.

Authors:  C S Landefeld; P A Anderson
Journal:  Ann Intern Med       Date:  1992-05-15       Impact factor: 25.391

7.  Endoscopic injection sclerosis: effective treatment for bleeding peptic ulcer.

Authors:  C Rajgopal; K R Palmer
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

8.  Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement.

Authors:  A G Turpie; J Gunstensen; J Hirsh; H Nelson; M Gent
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

9.  Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.

Authors:  J H Chesebro; V Fuster; L R Elveback; D C McGoon; J R Pluth; F J Puga; R B Wallace; G K Danielson; T A Orszulak; J M Piehler; H V Schaff
Journal:  Am J Cardiol       Date:  1983-05-15       Impact factor: 2.778

10.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

Authors:  R Hull; J Hirsh; R Jay; C Carter; C England; M Gent; A G Turpie; D McLoughlin; P Dodd; M Thomas; G Raskob; P Ockelford
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

View more
  32 in total

1.  Safety of esophagogastroduodenoscopy within 30 days of myocardial infarction: a retrospective cohort study from a Canadian tertiary centre.

Authors:  Fahad Al-Ebrahim; Khurram J Khan; Waleed Alhazzani; Ahmed Alnemer; Abdullah Alzahrani; John Marshall; David Armstrong
Journal:  Can J Gastroenterol       Date:  2012-03       Impact factor: 3.522

2.  Recurrent obscure gastrointestinal bleeding: time for provocative thinking?

Authors:  Steven B Ingle; Jeffrey A Alexander
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-07

3.  A 77-year-old man with nonvariceal upper gastrointestinal bleeding.

Authors:  Kyle J Fortinsky; Nathan M Stall; Alan N Barkun
Journal:  CMAJ       Date:  2014-01-06       Impact factor: 8.262

4.  Lower gastrointestinal bleeding during anticoagulant therapy: a life-saving complication?

Authors:  S A Norton; C P Armstrong
Journal:  Ann R Coll Surg Engl       Date:  1997-01       Impact factor: 1.891

Review 5.  Acute upper gastrointestinal bleeding in the elderly: aetiology, diagnosis and treatment.

Authors:  Asma Ahmed; Adrian J Stanley
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

6.  ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding.

Authors:  Lisa L Strate; Ian M Gralnek
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

7.  Adverse events associated with anticoagulation therapy in the periendoscopic period.

Authors:  Lauren B Gerson; LeAnn Michaels; Nighat Ullah; Brian Gage; Luke Williams
Journal:  Gastrointest Endosc       Date:  2010-06       Impact factor: 9.427

8.  Prevalence of significant neoplasia in FOBT-positive patients on warfarin compared with those not on warfarin.

Authors:  Lulu Iles-Shih; Judy F Collins; Jennifer L Holub; David A Lieberman
Journal:  Am J Gastroenterol       Date:  2010-08-03       Impact factor: 10.864

Review 9.  Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysis.

Authors:  Patrick Yachimski; Chin Hur
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

10.  Safety of push enteroscopy after recent myocardial infarction.

Authors:  Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.